Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
30 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/30/3107409/0/en/Chemomab-Announces-Oral-Presentation-of-Positive-Nebokitug-Phase-2-Clinical-Data-in-Primary-Sclerosing-Cholangitis-at-BSG-Live-25.html
11 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/11/3097491/0/en/Chemomab-Reports-Positive-Feedback-From-Two-Recent-FDA-Meetings-Supporting-Phase-3-Advancement-of-Nebokitug-in-Primary-Sclerosing-Cholangitis.html
03 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/03/3092706/0/en/Chemomab-Announces-New-Patent-Awards-for-Its-First-in-Class-Agent-Nebokitug-that-is-Positioned-to-Potentially-Become-the-First-Approved-Drug-for-Primary-Sclerosing-Cholangitis.html
15 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/15/3082095/0/en/Chemomab-Therapeutics-Announces-First-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3069120/0/en/Chemomab-Reports-New-Positive-Clinical-Data-at-EASL-2025-Supporting-Nebokitug-s-Impact-in-Primary-Sclerosing-Cholangitis-and-Related-Diseases.html
21 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/21/3064619/0/en/Chemomab-Therapeutics-to-Present-Nebokitug-Clinical-Data-at-Upcoming-Scientific-Conferences.html
ABOUT THIS PAGE